Home » ViaCell and Genzyme Announce Collaboration Agreement in Diabetes
ViaCell and Genzyme Announce Collaboration Agreement in Diabetes
March 15, 2005
ViaCell, Inc. and Genzyme Corporation announced that the two companies entered into a collaboration related to diabetes. Over the next 18 months Genzyme will conduct research to improve production and characterization of islet stem cells, and to undertake preclinical proof-of-concept studies for the transplantation of adult islet stem cells derived from donated pancreatic tissue. ViaCell will work with Genzyme and conduct complementary preclinical research. No financial terms of the agreement were announced.
Yahoo News (http://biz.yahoo.com/prnews/050315/netu002a_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct